C2orf34 Inhibitors
Wortmannin and LY-333531 target key kinases involved in cell survival and proliferation, potentially influencing any role C2orf34 has in these processes. PD0325901 and SB203580 specifically inhibit components of the MAPK pathway, which is a crucial signaling cascade that could intersect with C2orf34's functions. Dasatinib and PP2, by inhibiting Src family kinases, could disrupt multiple signaling pathways, thereby potentially altering the activity of C2orf34 if it is a part of these pathways.
Furthermore, compounds like Trichostatin A and 5-Azacytidine work on epigenetic levels, altering gene expression and protein function, a process in which C2orf34 could be implicated. MG132 interferes with protein degradation, possibly leading to an accumulation of proteins, including C2orf34, altering its cellular levels and activity. The effects of Rapamycin on the mTOR pathway, KN-93 on calcium signaling, and SP600125 on JNK signaling provide diverse mechanisms by which C2orf34's activity could be indirectly modulated, reflecting the complex network of intracellular interactions and the array of potential chemical interventions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can interfere with downstream signaling, potentially affecting pathways that C2orf34 may be part of. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src kinase inhibitor that can disrupt various signaling pathways, possibly including those associated with C2orf34. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can alter gene expression, potentially impacting the function of proteins like C2orf34. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can lead to increased levels of proteins, potentially affecting C2orf34 turnover. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
A PKC inhibitor that can modify signaling pathways, possibly influencing processes regulated by C2orf34. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could affect inflammation and stress response pathways involving C2orf34. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A selective Src family kinase inhibitor that could alter signaling cascades, potentially affecting C2orf34's role within them. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK signaling, possibly influencing C2orf34's function in stress response or apoptosis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can disrupt cell growth and proliferation pathways, possibly affecting C2orf34's regulation. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A CaMKII inhibitor that may alter calcium signaling pathways, potentially intersecting with C2orf34's activity. | ||||||